Clinical efficacy and changes of serum VEGF-A, VEGF-B, and PLGF after conbercept treating neovascular age-related macular degeneration.
Xiao-Dong ChenChan LiGuo-Long DingYan SuoYu-Sheng ZhuHui-Qin Lu
Published in: International journal of ophthalmology (2023)
Conbercept intravitreal injection leads to BCVA and CRT improvement, however, it does not significantly affect systemic serum VEGF-A, VEGF-B, and PLGF levels at 1 and 12mo after intravitreal injection treating neovascular AMD.